pharmaphorum Podcast
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Episodes
![Patient engagement strategies: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-43-1400x1400_300x300.jpg)
Friday Oct 29, 2021
Friday Oct 29, 2021
This episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s being led by Mark Duman, a clinician, consultant and patient advocate.
![BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-42-1400x1400_300x300.jpg)
Friday Oct 15, 2021
Friday Oct 15, 2021
Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.
![Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-41-1400x1400_300x300.jpg)
Monday Oct 04, 2021
Monday Oct 04, 2021
Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.
![Virtual engagement and collaborations: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-40-1400x1400_300x300.jpg)
Wednesday Sep 22, 2021
Wednesday Sep 22, 2021
As the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.
![Biotech Insight podcast: Overcoming planning challenges in oncology](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/khd_biotech_podcast_banner_-1400-x-1400_v2_300x300.jpg)
Wednesday Sep 08, 2021
Wednesday Sep 08, 2021
The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology.
![Vertex senior country manager Nicola Massey: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-39-1400x1400_300x300.jpg)
Monday Aug 23, 2021
Monday Aug 23, 2021
In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.
![Regenerative medicine and COVID: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-38-1400x1400_300x300.jpg)
Friday Aug 13, 2021
Friday Aug 13, 2021
In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine.
![Pharmacy and clinical research: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-37-1400x1400_300x300.jpg)
Wednesday Jun 30, 2021
Wednesday Jun 30, 2021
In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2.
The US-based company was founded in 2019 and is on a mission to bring the practice of pharmacy into clinical research.
![Pharma’s post-COVID prospects: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-36-1400x1400_300x300.jpg)
Friday May 28, 2021
Friday May 28, 2021
In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season.
![Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-35-1400x1400_300x300.jpg)
Friday Apr 30, 2021
Friday Apr 30, 2021
Episode 35 of the pharmaphorum podcast heard from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit.